Granules India

Granules India Secures USFDA Tentative Approval for Generic ADHD Tablets; Eligible for 180-Day Exclusivity

Granules India Secures USFDA Tentative Approval for Generic ADHD Tablets; Eligible for 180-Day Exclusivity

By Axel Miller | 08 Jan 2026

Granules India arm gets USFDA tentative nod for generic ADHD tablets with 180-day exclusivity eligibility, expanding its $213M CNS portfolio.

Granules India gets USFDA nod

By Our Corporate Bureau | 24 May 2004
View details about the software product Informachine News Trackers

Latest articles

Oswal Energies signs MoU with Abu Dhabi’s ATS, outlines $1 billion Middle East expansion

 Oswal Energies signs MoU with Abu Dhabi’s ATS, outlines $1 billion Middle East expansion

The New Oil (Part 4): Can Technology Break the Dependency?

 The New Oil (Part 4): Can Technology Break the Dependency?

L&T Wins ‘Large’ Petronet Contract to Build Storage at Dahej Petrochemical Complex

 L&T Wins ‘Large’ Petronet Contract to Build Storage at Dahej Petrochemical Complex

Wipro Beats Q3 Revenue Estimates on Growth in Americas Business

 Wipro Beats Q3 Revenue Estimates on Growth in Americas Business

Grasim Taps ITC Veteran Sachin Sahay to Lead Birla Opus in Paint Wars

 Grasim Taps ITC Veteran Sachin Sahay to Lead Birla Opus in Paint Wars

Italy Probes Microsoft Unit Over ‘Aggressive’ In-Game Sales in Call of Duty, Diablo

 Italy Probes Microsoft Unit Over ‘Aggressive’ In-Game Sales in Call of Duty, Diablo

Taiwan positions itself as strategic AI partner to US after tariff deal

 Taiwan positions itself as strategic AI partner to US after tariff deal

German AI Startup Parloa Jumps to $3 Billion Valuation in $350 Million Funding Round

 German AI Startup Parloa Jumps to $3 Billion Valuation in $350 Million Funding Round

Spotify to Raise US Premium Subscription Price to $12.99 From February

 Spotify to Raise US Premium Subscription Price to $12.99 From February